Eden Radioisotopes Advances $1.4 Billion Medical Isotope Project in New Mexico
Eden Radioisotopes has made significant progress toward developing a medical isotope production facility in Lea County, New Mexico. The project includes state support through various incentive programs and the selection of Kiewit Nuclear Solutions Co. as its EPC partner alongside continued collaboration with Sargent & Lundy for engineering and regulatory services. The $1.4 billion investment is expected to create 205 jobs in New Mexico, generating over $1.5 billion in economic impact over a decade. The facility will be the first purpose-built medical isotope production reactor in North America, addressing supply chain vulnerabilities by producing isotopes used for diagnostic imaging and cancer treatment. Eden filed its Construction Permit Application with the U.S. Nuclear Regulatory Commission in May 2026 and anticipates a decision mid-2027. The company aims to be commercially operational by 2030, leveraging New Mexico's nuclear expertise and workforce.
Topics: Infrastructure Investment Job Creation Medical Isotopes Nuclear Energy